SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061533
Filing Date
2023-11-09
Accepted
2023-11-09 07:30:23
Documents
51
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrx-20230930.htm   iXBRL 10-Q 2366288
2 EX-10.1 tcrx-ex10_1.htm EX-10.1 70614
3 EX-31.1 tcrx-ex31_1.htm EX-31.1 24188
4 EX-31.2 tcrx-ex31_2.htm EX-31.2 24196
5 EX-32.1 tcrx-ex32_1.htm EX-32.1 9388
  Complete submission text file 0000950170-23-061533.txt   6336602

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrx-20230930_lab.xml EX-101.LAB 386890
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrx-20230930_def.xml EX-101.DEF 197966
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrx-20230930_pre.xml EX-101.PRE 289378
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrx-20230930.xsd EX-101.SCH 42077
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrx-20230930_cal.xml EX-101.CAL 36692
45 EXTRACTED XBRL INSTANCE DOCUMENT tcrx-20230930_htm.xml XML 612190
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40603 | Film No.: 231390068
SIC: 2836 Biological Products, (No Diagnostic Substances)